PAPA JOSEPH C 4
4 · Emergent BioSolutions Inc. · Filed Mar 5, 2026
Insider Transaction Report
Form 4
PAPA JOSEPH C
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
[F1]2026-03-05$8.44/sh−37,055$312,744→ 305,445 total - Award
Employee Stock Option (Right to buy)
[F2]2026-03-03+252,194→ 1,784,694 totalExercise: $8.99Exp: 2033-03-02→ Common Stock (252,194 underlying)
Footnotes (2)
- [F1]Represents shares of common stock withheld to pay taxes associated with vesting and settlement of performance stock units.
- [F2]Vests in three equal installments beginning on the day prior to the anniversary date of the grant.
Signature
/s/ Richard S. Lindahl, Attorney-in-fact|2026-03-05